Nomura Holdings’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-31,149	Closed	-$153K	–	1380
2024 Q1	$153K	Buy	31,149 +8,649	+38%	+$42.6K	﹤0.01%	876
2023 Q4	$198K	Hold	22,500	–	–	﹤0.01%	980
2023 Q3	$258K	Buy	+22,500	New	+$258K	﹤0.01%	661